Filing metadata

Accession number
0001479290-22-000106
Form type
Form 4
Filer
Revance Therapeutics, Inc.
CIK
CIK 1479290
Filed
Dec 16, 2022
Reporting period
Dec 15, 2022
Description
Insider transaction

Explore SEC Filings Hub